Emergency: 911 Crisis: call or text 988 PA DDAP: 1-800-662-4357 PA 211: 2-1-1
24/7 Placement Advisors — Call (215) 792-4574

Heroin Rehab in Philadelphia, PA | Anchor Point Addiction Center

Fentanyl was detected in 93% of Philadelphia's opioid-involved overdose deaths in 2024 (Philadelphia Department of Public Health). Fentanyl is 50 to 100 times more potent than morphine (CDC), which is why its spread through the opioid supply has made overdose far more likely.

Is There Still 'Heroin' in Philadelphia?

In practical terms, very little. What is sold as heroin in Philadelphia is usually illicit fentanyl — either fentanyl alone or fentanyl combined with xylazine, medetomidine, or other adulterants. The implications for people seeking treatment are significant: fentanyl causes faster-onset, more intense withdrawal than heroin, is dramatically more potent (increasing overdose risk if relapse occurs), and is now mixed with non-opioid adulterants that require their own treatment protocols.

What Is Heroin / Opioid Rehab?

Opioid use disorder treatment — whether the primary substance is heroin, fentanyl, or prescription opioids — follows the same general framework: medical detox to manage withdrawal, followed by residential or intensive outpatient treatment, often with medication-assisted treatment (buprenorphine or methadone) as the pharmacological backbone. Inpatient programs offer the highest level of structure and support, which is particularly important during early recovery when the risk of relapse and fatal overdose is highest.

How Does Heroin Rehab in Philadelphia Work Today?

Heroin rehab in Philadelphia is, in practice, fentanyl-aware opioid treatment. The city's health department found fentanyl in 93% of opioid-involved overdose deaths in 2024 and xylazine in 34% of all overdose deaths, so placement advisors look for programs that can manage detox, wound care and medication for that mix, not heroin alone.

The Philadelphia Department of Public Health's 2024 report adds more detail on the local supply (Philadelphia Department of Public Health):
Overall: 1,069 unintentional overdose deaths in 2024, an 18% decrease from 2023. The 19134 ZIP code (Kensington and Port Richmond) had the most.
Medetomidine: detected in 9% of overdose deaths in 2024, and in 18% of opioid overdose deaths from May to December 2024.
Stimulants alongside opioids: opioids and stimulants were co-detected in half of all overdose deaths.

Each of those findings changes the treatment plan. Xylazine can leave serious wounds that need care during detox, and medetomidine withdrawal needs its own monitoring (see xylazine and medetomidine detox). Cocaine use alongside opioids means the program should treat both, not just the opioid. And because the opioid is almost always fentanyl, medication for opioid use disorder such as buprenorphine or methadone is part of the conversation from the first call. Naloxone reverses opioid overdoses, including fentanyl (CDC), so keep it nearby while placement is arranged. Call (215) 792-4574 to talk with a placement advisor.

Ready to Talk? Call (215) 792-4574 — Available 24/7.

Free insurance verification in minutes. We tell you what your plan covers in one call. Confidential, no obligation.

(215) 792-4574

Frequently Asked Questions

What's the difference between heroin rehab and fentanyl rehab?

In Philadelphia today, there is essentially no functional difference — fentanyl dominates the street opioid supply. Both require opioid-focused detox and residential treatment, typically with MAT. The specific clinical protocols may differ slightly based on adulterant presence (xylazine, medetomidine), but the treatment framework is the same.

Where can I find heroin rehab in Philadelphia?

Call (215) 792-4574. A placement advisor verifies your insurance and matches you with opioid detox and residential programs in the referral network in and around Philadelphia that can handle fentanyl, xylazine and medetomidine exposure.

Call Now